- The past week (October 31-November) in patents showed that Samsung has taken the lead over IBM in terms of the number of patents granted.
- Top industries remain in Consumer Electronics and Computer Manufacturing.
- Japan leads in terms of non-US assignee country, followed by Korea and Germany.
Parola Top Patents
We looked at the granted patents from October 31 to November 6 and here are our top patents:
10123199 | Trip anomaly detection system | Uber
A new security system by Uber will detect anomalies in the trip direction and alert both driver and passenger.
10118593 | Police vehicle monitor | Ford
A new system for police vehicles that will increase security and accessibility by using wearables to track officer location.
10121297 | Vision-based fare collection | Cubic Corporation
This vision-based system will detect your face and determine if you’ve paid your fare — providing an easier and ticketless commute.
10120945 | Content relevance in a social networking system using quality controlled human raters | Facebook, Inc.
With this content-relevance check, fake or sensationalized content can now be detected in social media platforms.
10120442 | Eye tracking using a light field camera on a head-mounted display | Oculus VR
A better control system for VR head-mounted displays can be achieved by detecting the eye location and direction using plenoptic cameras.
10120193 | Geometric phase lens alignment in an augmented reality head mounted display | Oculus VR
Oculus VR’s new patent is geared towards the continuous improvement of HMDs. The patent discloses a solution to vergence-accommodation conflict of AR HMD systems via geometric phase lens.
10121190 | System and method of sharing an augmented environment with a companion | Capital One Services, LLC
It can now be possible to share an experience with a friend or loved-one far-away with this AR/VR system.
10120979 | Predicting glucose trends for population management | Cerner
Cerner’s patent discloses a predictive model based on multiple patients and multiple venues to identify persons at risk for abnormal glucose levels.